Connecticut · 87522

Detection Test By Nucleic Acid For Hepatitis C Virus, Quantification in Connecticut

Connecticut Medicare Avg
$41.98
0% above national avg
National Medicare Avg
$41.94
All states combined
Billed Charge (CT)
$297.73
What providers submit
Est. Commercial (CT)
$107.05
National avg: $93.96
Est. Cash / Self-Pay (CT)
$113.36
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

21
Services in CT
2
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Connecticut

Provider Medicare Services
Collaborative Laboratory Services... $41.98 18

Connecticut Pricing in Context

In Connecticut, CPT code 87522 (Detection Test By Nucleic Acid For Hepatitis C Virus, Quantification) carries an average Medicare payment of $41.98 — 0% above the national benchmark of $41.94. 2 providers across the state submitted claims for this procedure in 2023, performing 21 total services. Individual payments in CT ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Connecticut is $297.73, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Connecticut sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Laboratory procedures, the estimated commercial insurance price in Connecticut lands near $107.05, with self-pay cash prices typically around $113.36. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Detection Test By Nucleic Acid For Hepatitis C Virus, Quantification cost in Connecticut?

The average Medicare payment for Detection Test By Nucleic Acid For Hepatitis C Virus, Quantification in Connecticut is $41.98, which is 0% above the national average of $41.94. Providers in CT typically bill $297.73 for this procedure.

What does Detection Test By Nucleic Acid For Hepatitis C Virus, Quantification cost with insurance in Connecticut?

With commercial insurance in Connecticut, Detection Test By Nucleic Acid For Hepatitis C Virus, Quantification costs an estimated $107.05. Without insurance, the estimated cash price is $113.36. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Detection Test By Nucleic Acid For Hepatitis C Virus, Quantification in Connecticut?

2 providers in Connecticut billed Medicare for Detection Test By Nucleic Acid For Hepatitis C Virus, Quantification in 2023, performing 21 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Detection Test By Nucleic Acid For Hepatitis C Virus, Quantification cheaper in Connecticut than the national average?

No — Detection Test By Nucleic Acid For Hepatitis C Virus, Quantification costs 0% above the national average in Connecticut. The state average Medicare payment is $41.98 compared to $41.94 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial